NRXS: Bathi resik saben saham (EPS TTM) NeurAxis

The rolling annual earnings per share of NeurAxis, Inc. (NRXS) demonstrates the efficiency of neuro-equipment distribution through optimized supply channels, while the -1.07 level captures the current state of the metric. Capitalization growth relies on the adoption rates of stimulators and their approval by US insurers. The business's environmental focus is highlighted by the implementation of recyclable materials and the development of digital diagnostics to reduce patient travel.

Localizing the assembly of neurostimulators in the US minimizes logistical risks for NeurAxis, Inc. This trailing twelve-month (TTM) net income per share converts the aggregate financial result into specific earnings per share. This metric strips the bottom line of the impact of share issuance, revealing the actual efficiency of capital. The trend in trailing twelve-month net income per share reflects the impact of operating expenses on margins, allowing investors to assess the business's resilience to inflationary pressure.